As of July 2026, 37 paid clinical trials are recruiting for Oncology in La Crosse, Wisconsin. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
La Crosse has approximately 98 recruiting research studies across a wide range of therapeutic areas. Wisconsin hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Researchers run research studies in La Crosse, WI at 19 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Gundersen Lutheran Medical Center | Stage IV Lung Cancer AJCC v8, Acute Myeloid Leukemia, Stage IIIB Lung Cancer AJCC v8 | 64 |
| Mayo Clinic Health System-Franciscan Healthcare | Breast Cancer, Stage III Prostate Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 12 |
| Gundersen Health System | Geographic Atrophy Secondary to Age-related Macular Degeneration, Amblyopia, Arthroplasties, Knee Replacement | 8 |
| Gundersen Health System, Merz Investigational | Chronic Migraine, Episodic Migraine | 2 |
| Gundersen Health System - La Crosse Medical Center | AMD, CNV, Wet Age-related Macular Degeneration | 2 |
| Gundersen Health | Coronary Artery Disease, Ischemic Heart Disease | 1 |
| Gundersen Health System - La Crosse Campus | Allergy, Peanut Allergy | 1 |
| Gundersen Lutheran | Coronary Artery Disease | 1 |
| Gundersen Lutheran Medical Foundation | Epidermal Growth Factor Receptor Gene Mutation, Non Small Cell Lung Cancer, Stage III Lung Cancer | 1 |
| Gundersen Lutheran Medical Foundation (Data Collection Only) | Hepatectomy | 1 |
| Gunderson Health | Breast Cancer, Early Stage Breast Cancer, HER2 + Breast Cancer | 1 |
| Gunderson Health System | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 1 |
| La Crosse Mayo Clinic | Alzheimer Disease and Related Dementias (ADRD), Hearing Loss, Mild Cognitive Impairment | 1 |
| Mayo Clinic Health System - La Crosse | Breast Cancer | 1 |
| Mayo Clinic Health System - Southwest Wisconsin | Adnexal Mass, Atypical Endometrial Hyperplasia, Cervical Cancer | 1 |
| Mayo Clinic Health System SW Wisconsin | Cardiovascular Diseases, Cognitive Impairment, Mild, Dementia | 1 |
| Mayo Clinic Health System- La Crosse | Lumbar Spinal Stenosis | 1 |
| Mayo Clinic Health System-La Crosse | Community-acquired Pneumonia | 1 |
| University of Wisconsin La Crosse | Inflammation, Peripheral Arterial Disease, Walking, Difficulty | 1 |
Recruiting trials in La Crosse grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Wisconsin are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Wisconsin research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in La Crosse from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 98 recruiting clinical trials in La Crosse, Wisconsin listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in La Crosse compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in La Crosse include Stage IV Lung Cancer AJCC v8 (6), Acute Myeloid Leukemia (5), Breast Cancer (5), Stage IIIB Lung Cancer AJCC v8 (5), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in La Crosse on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in La Crosse include Gundersen Lutheran Medical Center, Mayo Clinic Health System-Franciscan Healthcare, Gundersen Health System, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in La Crosse are Cancer & tumors (72), Eye & vision (4), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.